Geode Capital Management, LLC Neoleukin Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.4 - $0.55 $290 - $399	-726 Reduced 0.24%	301,057 $153,000
Q2 2022 Aug 12, 2022	SELL	$0.92 - $2.25 $261,947 - $640,631	-284,725 Reduced 48.55%	301,783 $310,000
Q1 2022 May 13, 2022	SELL	$1.72 - $5.23 $2,805 - $8,530	-1,631 Reduced 0.28%	586,508 $1.1 Million
Q4 2021 Feb 11, 2022	SELL	$4.65 - $7.75 $138,049 - $230,082	-29,688 Reduced 4.81%	588,139 $2.83 Million
Q3 2021 Nov 12, 2021	BUY	$6.05 - $9.66 $212,972 - $340,051	35,202 Added 6.04%	617,827 $4.47 Million
Q2 2021 Aug 13, 2021	BUY	$9.23 - $13.12 $418,885 - $595,424	45,383 Added 8.45%	582,625 $5.38 Million
Q1 2021 May 12, 2021	BUY	$11.26 - $15.78 $697,399 - $977,350	61,936 Added 13.03%	537,242 $6.61 Million
Q4 2020 Feb 12, 2021	BUY	$10.17 - $14.56 $317,863 - $455,072	31,255 Added 7.04%	475,306 $6.7 Million
Q3 2020 Nov 13, 2020	BUY	$9.68 - $17.01 $73,277 - $128,765	7,570 Added 1.73%	444,051 $5.33 Million
Q2 2020 Aug 13, 2020	BUY	$9.95 - $17.05 $1.45 Million - $2.48 Million	145,581 Added 50.05%	436,481 $7.25 Million
Q1 2020 May 14, 2020	BUY	$6.12 - $13.64 $114,388 - $254,945	18,691 Added 6.87%	290,900 $3.31 Million
Q4 2019 Feb 13, 2020	BUY	$2.65 - $12.72 $269,224 - $1.29 Million	101,594 Added 59.55%	272,209 $3.35 Million
Q3 2019 Nov 12, 2019	BUY	$2.33 - $3.76 $397,532 - $641,512	170,615 New	170,615 $486,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.